204 Followers on Owler
OverviewCompetitorsFundingNews & Insights

NexImmune Competitors or Alternatives

NexImmune's top competitors include Mustang Bio, Adaptimmune and Fate Therapeutics.

Unlock 15 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

NexImmune's company profile

Kristi Jones

CEO

86/100
6
$166.4M
$ < 1M
  • $166.4M
    $ < 1M
  • 6
    $166.4M
  • $ < 1M
  • 86/100
  • 6
  • $166.4M
  • $ < 1M
View ProfileView
1
NexImmune's Competitor - Mustang Bio logo

Manuel Litchman

President & CEO

90/100
100
$354.3M
$2.4M
  • $354.3M
    $2.4M
  • 100
    $354.3M
  • $2.4M
  • 90/100
  • 100
  • $354.3M
  • $2.4M
View ProfileView
2
NexImmune's Competitor - Adaptimmune logo

Adrian Rawcliffe

CEO

84/100
506
$683.7M
$178M
  • $683.7M
    $178M
  • 506
    $683.7M
  • $178M
  • 84/100
  • 506
  • $683.7M
  • $178M
View ProfileView
3
NexImmune's Competitor - Fate Therapeutics logo

Bahram Valamehr

President & CEO

82/100
550
$366.3M
$13.6M
  • $366.3M
    $13.6M
  • 550
    $366.3M
  • $13.6M
  • 82/100
  • 550
  • $366.3M
  • $13.6M
View ProfileView
4
NexImmune's Competitor - Novartis logo

Vasant Narasimhan

CEO

74/100
75,883
- -
$50.3B
  • - -
    $50.3B
  • 75,883
    - -
  • $50.3B
  • 74/100
  • 75,883
  • - -
  • $50.3B
View ProfileView
5
NexImmune's Competitor - Gilead logo

Daniel O’Day

Chairman & CEO

66/100
17,000
$7.5B
$28.8B
  • $7.5B
    $28.8B
  • 17,000
    $7.5B
  • $28.8B
  • 66/100
  • 17,000
  • $7.5B
  • $28.8B
View ProfileView
NexImmune's top 18 competitors are Mustang Bio, Adaptimmune, Fate Therapeutics, Bristol-Myers Squibb, Novartis, Gilead, Immatics, Iovance, Atara, Marker Therapeutics, SQZ Biotech, BioNTech, Moderna, Amgen, Johnson & Johnson, Elstar Therapeutics, Cedilla and CR Pharmaceutical. Together they have raised over 46.3B between their estimated 392.2K employees. NexImmune has 6 employees and is ranked 19th among it's top 10 competitors. The top 10 competitors average 20,643.

NexImmune VS Mustang Bio

Mustang Bio is NexImmune's #1 competitor. Mustang Bio's headquarters is in Worcester, New York, and was founded in 2015. Like NexImmune, Mustang Bio also works within the Biotechnology sector. Mustang Bio generates ∞% of NexImmune's revenue.

NexImmune VS Adaptimmune

Adaptimmune is one of NexImmune's top rivals. Adaptimmune was founded in Oxfordshire, England} in 2008. Adaptimmune operates in the Biotechnology industry. Compared to NexImmune, Adaptimmune generates $178M more revenue.

NexImmune VS Fate Therapeutics

Fate Therapeutics is one of NexImmune's top competitors. Fate Therapeutics is a Public company that was founded in 2007 in San Diego, California. Fate Therapeutics is in the Biotechnology industry. Compared to NexImmune, Fate Therapeutics has 544 more employees.

Looking for similar companies to NexImmune?

Similar Companies

Biotechnology companies in Gaithersburg

See 47 companies 
Companies in Gaithersburg with employees in 1-25 range

See 152 companies 
Pharmaceuticals & Biotechnology companies in Gaithersburg

See 60 companies 
Biotechnology companies in Washington Metropolitan Area

See 351 companies 
Biotechnology companies in Maryland

See 395 companies 
Pharmaceuticals & Biotechnology companies in Washington Metropolitan Area

See 494 companies 
Pharmaceuticals & Biotechnology companies in Maryland

See 526 companies 
Biotechnology companies with employees in 1-25 range

See 3,305 companies 
Pharmaceuticals & Biotechnology companies with employees in 1-25 range

See 4,662 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for NexImmune and NexImmune's Competitors

Today 9:08 AMPharmabiz
Novartis announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate─...
Today 9:06 AMPharmabiz
Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ap...
Today 2:00 PMFinanzNachrichten
CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TG...
Today 1:24 PMcentralcharts
Lead program investigating MT-601 in patients with refractory lymphomas, including anti-CD19 CAR-T cell therapy, demonstrated safety and efficacy in 9 ...
March 29, 2025The Robot Report
Johnson & Johnson designed Dualto to deliver the choice of powering monopolar, bipolar, ultrasonic, or advanced bipolar instruments.The post Johnson & ...
March 29, 2025Tipranks
In a report released yesterday, Tim Anderson from Bank of America Securities maintained a Hold rating on Pfizer ( PFE - Research Report ), with a price...
Today 4:54 PMInvesting.com
Moderna stock hits 52-week low at $28.75 amid market challenges...
March 29, 2025Medthority
Pluvicto (lutetium Lu-177) approved for PSMA-positive metastatic prostate cancer. Novartis delays chemotherapy....
Today 3:27 PMOwler
Marker Therapeutics’s Trailing Twelve Months revenue changed from $5.40M in Sep 2024 to $6.59M in Dec 2024 increasing 22.2% in this time period....
Today 12:14 PMInvesting.com
Moderna Falls 12% on Concerns About Vaccine Regulations...

Frequently Asked Questions about NexImmune

  1. Who are NexImmune's top competitors?

    NexImmune's top 3 competitors are Mustang Bio, Adaptimmune, Fate Therapeutics.

  2. Who is similar to NexImmune?

    Mustang Bio is the most similar to NexImmune. Adaptimmune and Fate Therapeutics are also similar to NexImmune.

  1. Are NexImmune and Mustang Bio competitors?

    Yes, Mustang Bio is one of NexImmune’s top competitors.